Sumiyoshi Sayoko, Takahara Terumi, Shibuya Kazuto, Imura Johji, Noguchi Akira, Tajiri Kazuto, Minemura Masami, Fujii Tsutomu, Hirabayashi Kenichi
Department of Diagnostic Pathology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan.
Third Department of Medicine, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan.
Oncol Lett. 2024 Feb 22;27(4):168. doi: 10.3892/ol.2024.14301. eCollection 2024 Apr.
The development of tumors in livers transplanted from hepatitis B virus (HBV)-negative donors to patients with hepatitis B and cirrhosis is rare. The present study describes the case of a woman in her 60s who developed hepatocellular carcinoma (HCC) in her grafted liver, 19 years after transplantation, as well as a metachronous colorectal tumor. The pathological findings, including clinical, immunohistochemical and molecular results, are described in the present case report. The liver tumor was a conventional HCC and the colorectal tumor comprised a tubular adenocarcinoma. Immunohistochemistry of both tumors showed a loss of expression of mutL homolog 1 and postmeiotic segregation increased 2 in the tumor cells, confirming microsatellite instability-high (MSI-H) status. Furthermore, a molecular study detected the presence of genes located on the Y chromosome in the normal and tumor tissues of the liver, proving that the HCC occurred in the grafted liver. The present report also discusses that prolonged use of immunosuppressive drugs to prevent post-transplant rejection, poorly controlled diabetes mellitus and MSI-H may have contributed to the risk of tumor development.
将乙肝病毒(HBV)阴性供体的肝脏移植给乙肝和肝硬化患者后发生肿瘤的情况较为罕见。本研究描述了一名60多岁女性的病例,该患者在移植19年后,其移植肝中发生了肝细胞癌(HCC),同时还出现了异时性结直肠肿瘤。本病例报告描述了包括临床、免疫组化和分子结果在内的病理发现。肝脏肿瘤为典型的HCC,结直肠肿瘤为管状腺癌。两种肿瘤的免疫组化均显示肿瘤细胞中mutL同源物1表达缺失和减数分裂后分离增加2,证实为微卫星高度不稳定(MSI-H)状态。此外,一项分子研究在肝脏的正常组织和肿瘤组织中检测到了位于Y染色体上的基因,证明HCC发生在移植肝中。本报告还讨论了长期使用免疫抑制药物预防移植后排斥反应、控制不佳的糖尿病和MSI-H可能增加了肿瘤发生的风险。